<?xml version="1.0" encoding="UTF-8"?>
<p>Passive immunotherapeutic strategies like convalescent plasma (CP) therapy have been used by several countries to treat patients suffering from severe SARS-CoV-2 infection [
 <xref rid="RSOB200174C18" ref-type="bibr">18</xref>,
 <xref rid="RSOB200174C19" ref-type="bibr">19</xref>]. CP has proved its effectiveness in neutralizing viruses like SARS-CoV, MERS-CoV, Ebola and H1N1. So, in this pandemic situation of COVID-19, globally, CP therapy has been explored for an effective line of treatment [
 <xref rid="RSOB200174C20" ref-type="bibr">20</xref>,
 <xref rid="RSOB200174C21" ref-type="bibr">21</xref>].
</p>
